Statistics for STARTVerso1: A Randomized Trial of Faldaprevir Plus Pegylated Interferon/Ribavirin for Chronic HCV Genotype-1 Infection
Total visits
| views | |
|---|---|
| STARTVerso1: A Randomized Trial of Faldaprevir Plus Pegylated Interferon/Ribavirin for Chronic HCV Genotype-1 Infection | 58 |
Total visits per month
| views | |
|---|---|
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| J Hepatol 2015.pdf(legacy) | 182 |
| J Hepatol 2015.pdf | 12 |
Top country views
| views | |
|---|---|
| United States | 36 |
| China | 11 |
| Canada | 2 |
| United Kingdom | 2 |
| Australia | 1 |
| Egypt | 1 |
| France | 1 |
| Italy | 1 |
| Japan | 1 |
| South Korea | 1 |